e-learning
resources
Milan 2017
Sunday, 10.09.2017
Novel mechanisms and treatments for COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of the state of endothelium on clinical and functional parameters in COPD patients with arterial hypertension.
O. Titova (ST PETERSBURG, Russian Federation)
Source:
International Congress 2017 – Novel mechanisms and treatments for COPD
Session:
Novel mechanisms and treatments for COPD
Session type:
Oral Presentation
Number:
1489
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Titova (ST PETERSBURG, Russian Federation). Impact of the state of endothelium on clinical and functional parameters in COPD patients with arterial hypertension.. 1489
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 768s
Year: 2007
Daily monitoring parameters of arterial stiffness and central aortic pressure in COPD patients comorbid with arterial hypertension
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
Impact of long-term oxygen therapy on systemic inflammation, morphological changes of red blood cells, pulmonary hemodynamics and diaphragm function in patients with chronic obstructive pulmonary disease.
Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD
Year: 2018
Impact of functional class change on survival in patients with pulmonary arterial hypertension in the REVEAL registry
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011
Clinical, functional and hemodynamic response after six months of sildenafil in patients with pulmonary arterial hypertension
Source: Annual Congress 2007 - Pulmonary circulation
Year: 2007
Screening for pulmonary vascular disease (PVD) in patients with portal hypertension by investigating pulmonary hemodynamics during exercise
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Effect of selexipag on long-term outcomes in key subgroups of patients with pulmonary arterial hypertension (PAH): GRIPHON study results
Source: International Congress 2015 – Pulmonary hypertension: new treatment insights
Year: 2015
Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: role of the pre-capillary component
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017
Increased arterial remodelling in smokers and mild-moderate COPD patients are indicative of potential early onset of pulmonary hypertension.
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021
Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension
Source: Eur Respir J, 50 (3) 1700784; 10.1183/13993003.00784-2017
Year: 2017
Effect of riociguat on haemodynamic parameters and exercise capacity in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension
Year: 2009
The change of lung diffusion capacity does not influence the prognosis in patients with pulmonary arterial hypertension associated with systemic sclerosis.
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019
Hemodynamics as a substitute for exercise capacity endpoints in patients with pulmonary arterial hypertension (PAH): A model based assessment for sildenafil
Source: Annual Congress 2010 - Present and future medical management of pulmonary arterial hypertension
Year: 2010
Effects of pulmonary rehabilitation in COPD patients with increased baseline arterial stiffness: The CIROCO study
Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care
Year: 2010
Functional impact of exercise pulmonary hypertension in patients with borderline pulmonary arterial pressure
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Clinical characteristics, haemodynamics, and survival in patients with combined pulmonary fibrosis and emphysema and associated pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary vascular medicine
Year: 2008
Tadalafil improves exercise capacity and delays time to clinical worsening in patients with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2008 - Medical treatment of pulmonary hypertension
Year: 2008
Microvascular changes in COPD patients with severe pulmonary hypertension
Source: International Congress 2017 – Imaging and lung disease PH
Year: 2017
Prognostic relevance of changes in exercise parameters in pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept